Interaction of transcription factor AP‐2 gamma with proto‐oncogene PELP1 promotes tumorigenesis by enhancing RET signaling

A significant proportion of estrogen receptor‐positive (ER+) breast cancer (BC) initially responds to endocrine therapy but eventually evolves into therapy‐resistant BC. Transcription factor AP‐2 gamma (TFAP2C) is a known regulator of ER activity, and high expression of TFAP2C is associated with a d...

詳細記述

書誌詳細

主要な著者:	Junhao Liu, Zexuan Liu, Mengxing Li, Weiwei Tang, Uday P. Pratap, Yiliao Luo, Kristin A. Altwegg, Xiaonan Li, Yi Zou, Hong Zhu, Gangadhara R. Sareddy, Suryavathi Viswanadhapalli, Ratna K. Vadlamudi
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2021-04-01
シリーズ:	Molecular Oncology
主題:	breast cancer coactivator PELP1 TFAP2C therapy resistance
オンライン･アクセス:	https://doi.org/10.1002/1878-0261.12871
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!